PURE Bioscience, Inc.
PURE · OTC
7/31/2025 | 7/31/2024 | 7/31/2023 | 7/31/2022 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$2,399,000 | -$3,350 | -$3,961 | -$3,491 |
| Dep. & Amort. | $2,000 | $148 | $117 | $213 |
| Deferred Tax | $0 | $0 | $107 | $0 |
| Stock-Based Comp. | $147,000 | $214 | $324 | $567 |
| Change in WC | $235 | $397 | -$107 | $103 |
| Other Non-Cash | $234,765 | $60 | $242 | $190 |
| Operating Cash Flow | -$2,015,000 | -$2,531 | -$3,278 | -$2,418 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | -$33 | -$81 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | $0 | $0 | -$33 | -$81 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $2,000 | $1,785 | $1,015 | $0 |
| Stock Issued | $0 | $0 | $0 | $3,500 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $1,998,000 | $0 | $0 | $0 |
| Financing Cash Flow | $2,000,000 | $1,785 | $1,015 | $3,500 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | -$15,000 | -$746 | -$2,296 | $1,001 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $424,000 | $1,170 | $3,466 | $2,465 |
| End Cash | $409,000 | $424 | $1,170 | $3,466 |
| Free Cash Flow | -$2,015,000 | -$2,531 | -$3,311 | -$2,499 |